Drug Lord Tycoon
Duhndal · 2024 · $9.99 · Action · deal grade B
Measured on 2026-10-05 04:18 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.
- Estimated net residual revenue: $569 to $854 per month
- Opportunity: $925 per month at x1.30 dormancy
- Estimated lifetime owners: 66.8k
- 83% positive across 1714 reviews · 9.7 reviews/month
Why it's flagged
- Developer active, last post 5 months ago
- Store page localized in only 1 language(s)
- Last discounted 0 months ago, 5 sales in the last 12 months
Analyst notes (AI-assisted)
Note written 2026-09-02; the live figures above take precedence over any numbers in it.
Early-access idle-management game where players build a drug empire through resource acquisition and reinvestment loops.
Drug Lord Tycoon sits in a quiet but resilient niche: a single-developer title that has sustained solid four-figure monthly residuals and 83% positive sentiment across a mid-sized owner base despite zero promotional spend in the past year. The game's long early-access window (nearly 4 years) and minimal developer communication suggest a mature, hands-off stance. This is not a portfolio addition for aggressive scaling, but a candidate for passive acquisition, light publishing support, or community-driven revival if the IP or meme value aligns with a publisher's catalog strategy. The low player count (9 concurrent, 35 peak-30d) and shallow review feedback indicate a game that has found its audience but lacks momentum to grow beyond it. Most realistic play: acquisition.
- Risk: Idle/tycoon genre saturation on Steam means new content or thematic hooks are critical to re-engagement; thematic novelty (drug trade framing) may narrow appeal and create platform-visibility headwinds.
- Risk: Early-access status after 4 years raises questions about development roadmap clarity and whether 1.0 launch is planned; lack of recent dev communication compounds uncertainty.
- Risk: Sole developer and single-title studio create knowledge-transfer and continuity risk if acquisition includes transition.
This case as Markdown · Estimates carry ±30-50% error per title.